Same Drug Class

Osimertinib vs Upadacitinib

Osimertinib vs Upadacitinib: Overview

This comparison examines the pharmacological differences between Osimertinib and Upadacitinib.

Mechanism of Action

Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.

Pharmacokinetics

Half-life: Osimertinib — 48 hours; Upadacitinib — 9-14 hours.

Chemical Properties

Molecular Formula: Osimertinib — C28H33N7O2; Upadacitinib — C17H19F3N6O.

Molecular Weight: Osimertinib — 499.6050 g/mol; Upadacitinib — 380.3700 g/mol.

Type: Osimertinib — Small molecule; Upadacitinib — Small molecule.